Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1298, 2001-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Gatifloxacin-containing regimens cost saving in CAP
Inpharma, Vol. 1, Iss. 1417, 2003-01 ,pp. :
Access to resources
Recommend
Alteplase: a Safe and Cost‐Effective Alternative to Urokinase
JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 32, Iss. 2, 2002-06 ,pp. :
Telithromycin appears to be cost effective for CAP
Inpharma, Vol. 1, Iss. 1547, 2006-01 ,pp. :
Telithromycin appears to be cost effective for CAP
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 507, 2006-01 ,pp. :
First-line sunitinib cost-effective alternative to interferon-α in renal cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 561, 2008-01 ,pp. :